Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis

Medicine & Life Sciences

• Adenosine Triphosphate 5%
• Animal Models 5%
• Antigen Presentation 7%
• Antigens 4%
• Breast Neoplasms 49%
• Calreticulin 19%
• Cell Survival 5%
• Chemokines 6%
• Clinical Trials 4%
• Cytokines 4%
• Dendritic Cells 6%
• Galactosylceramides 11%
• Glycolipids 8%
• HMGB1 Protein 9%
• Immunogenic Cell Death 22%
• Immunotherapy 68%
• In Vitro Techniques 6%
• Intravenous Administration 6%
• Messenger RNA 4%
• Natural Killer T-Cells 93%
• Neoplasm Metastasis 48%
• Neoplasms 6%
• Oncolytic Viruses 29%
• Ovarian Neoplasms 71%
• Peritoneal Neoplasms 9%
• Theoretical Models 5%
• Therapeutics 12%
• Tumor Burden 13%
• Vesicular Stomatitis 100%
• Virus Diseases 5%
• Viruses 52%